Since liposuction is designed to eliminate fat cells that are resistant to diet and exercise, the procedure is most effective for patients that are at or near their ideal weightand have maintained it for several months to one year prior to surgery
Its developer, Eli Lilly, calls it a triple-G agonist, referring to the three pathways it activates: GLP-1, GIP, and glucagon
These agonists/analogues of GLP-1 slow down gastric emptying, modulate calorie intake by increasing the sense of satiety, modulate cardiovascular activity, and regulate natriuresis at the renal level [6]
Rare but important risks include pancreatitis, gallbladder problems, dehydration from severe vomiting/diarrhoea, and potential worsening of diabetic eye disease in people with diabetes